Our Pricing

Essential Tips: What Medicines Can You Not Take With Mounjaro

Understanding which medicines you cannot take with Mounjaro UK is crucial for safe and effective weight loss treatment. As a UK-registered pharmacy with thousands of Mounjaro patients under our care, we've compiled this comprehensive guide to help you navigate medication interactions, contraindications, and safe prescribing practices. All Mounjaro prescriptions at Cured Pharmacy require clinical assessment by a UK prescriber to ensure your complete medication history is reviewed.

How Mounjaro Interacts With Other Medications

Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist that slows gastric emptying and affects how your body absorbs other medications [1]. This mechanism means tirzepatide can delay the absorption of oral medicines taken at the same time, potentially reducing their effectiveness or altering their blood levels.

The most clinically significant interactions occur with medications that require precise timing or consistent blood levels. In the SURPASS clinical trial programme, researchers carefully monitored patients taking concurrent medications to establish safety profiles [1]. Your UK prescriber will review your complete medication list during consultation to identify potential interactions.

Importantly, Mounjaro does not chemically interact with most medications in the bloodstream. Instead, it affects the timing and rate of absorption through the digestive system. This distinction is crucial because many interactions can be managed through dose timing adjustments rather than complete medication avoidance.

Diabetes Medications: Critical Interactions to Know

If you're taking insulin or sulphonylureas (such as gliclazide, glimepiride, or glipizide), combining these with Mounjaro significantly increases your risk of hypoglycaemia (dangerously low blood sugar) [2]. This is the most serious drug interaction UK prescribers assess before starting tirzepatide treatment.

Patients in the SURPASS-3 trial who were taking background insulin required dose reductions of up to 20% when starting Mounjaro to prevent hypoglycaemic episodes [1]. Your prescriber may need to reduce your insulin dose before you begin treatment, and you'll require more frequent blood glucose monitoring during the first few weeks.

Other diabetes medications like metformin, SGLT2 inhibitors (empagliflozin, dapagliflozin), and DPP-4 inhibitors (sitagliptin, linagliptin) have lower interaction risks, but your UK clinical team will still review the combined glucose-lowering effect. Never adjust diabetes medication doses yourself — always consult your prescriber first.

Managing Blood Sugar Safely

UK prescribers typically recommend checking blood glucose levels more frequently during the first month of Mounjaro treatment, particularly if you're on insulin or sulphonylureas. Symptoms of hypoglycaemia include shakiness, sweating, confusion, and rapid heartbeat — if you experience these, check your blood sugar immediately and consume fast-acting carbohydrates if levels are below 4 mmol/L.

Oral Contraceptives and Hormone Medications

Mounjaro's effect on gastric emptying can reduce the absorption of oral contraceptive pills, particularly during the first four weeks of treatment when gastrointestinal side effects are most pronounced [3]. The MHRA guidance for tirzepatide advises women of childbearing potential to use additional barrier contraception methods for four weeks after starting Mounjaro and after each dose increase.

This interaction doesn't mean you must stop taking oral contraceptives, but you should use condoms or another barrier method as backup during the adjustment period. Long-acting contraceptives like the coil (IUD), implant, or contraceptive injection are not affected by Mounjaro because they don't rely on gastrointestinal absorption.

If you're taking hormone replacement therapy (HRT) or thyroid medications like levothyroxine, similar absorption concerns apply. Your UK prescriber may recommend taking these medications at least one hour before or four hours after your Mounjaro injection to minimise interaction risk.

Medications That Require Dose Timing Adjustments

Certain medications require consistent blood levels to work effectively, and Mounjaro's gastric-slowing effect means timing becomes crucial. Antibiotics, particularly those requiring specific dosing intervals, may need to be taken at least one hour before Mounjaro or several hours after to ensure proper absorption.

Warfarin, a blood-thinning medication, requires special attention when starting Mounjaro. Changes in dietary habits and weight loss can affect warfarin's effectiveness, necessitating more frequent INR monitoring during the first three months of tirzepatide treatment [4]. Your anticoagulation clinic will adjust your warfarin dose based on these readings.

Thyroid medications (levothyroxine, liothyronine) should be taken on an empty stomach at least 30 minutes before breakfast, whilst Mounjaro can be taken at any time of day regardless of meals. UK prescribers typically recommend taking thyroid medication in the morning and Mounjaro in the evening to maximise separation.

Optimising Medication Timing

A practical approach is to take time-sensitive medications first thing in the morning, at least one hour before food, and administer your weekly Mounjaro injection in the evening. This schedule ensures maximum absorption of both treatments. Keep a medication diary during your first month to track timing and any gastrointestinal symptoms that might affect absorption.

Absolute Contraindications: When Mounjaro Cannot Be Prescribed

Mounjaro is absolutely contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) [1]. In rodent studies, tirzepatide caused thyroid C-cell tumours, and whilst this has not been observed in humans, the MHRA maintains this as a strict contraindication.

You cannot take Mounjaro if you have a history of severe allergic reaction (anaphylaxis) to tirzepatide or any excipients in the formulation. Additionally, patients with a history of pancreatitis should discuss risks carefully with their prescriber, as GLP-1 receptor agonists have been associated with acute pancreatitis in rare cases [2].

Pregnancy and breastfeeding are contraindications for Mounjaro treatment. The medication should be discontinued at least two months before a planned pregnancy, as weight loss during pregnancy is not recommended and animal studies showed potential foetal harm [3]. UK prescribers at Cured Pharmacy will confirm pregnancy status before prescribing to women of childbearing age.

Safe Mounjaro Prescribing at Cured Pharmacy

Every Mounjaro prescription at Cured Pharmacy begins with a comprehensive online consultation reviewed by our UK-registered clinical team. You'll be asked detailed questions about your current medications, medical history, allergies, and any previous adverse drug reactions to identify potential interactions before treatment starts.

Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), oversees all clinical assessments to ensure MHRA and NICE guidelines are followed. If your medication history reveals potential interactions, our prescribers will contact you directly to discuss dose timing adjustments, medication alternatives, or whether Mounjaro is the safest option for your circumstances.

Mounjaro is available from £135.00 at Cured Pharmacy, with pricing confirmed before your consultation. All patients receive detailed patient information leaflets, injection technique guidance, and access to our clinical team for ongoing medication queries throughout treatment. Your safety is our priority, which is why we never prescribe Mounjaro without thorough medication interaction screening.

Ongoing Medication Monitoring

After starting Mounjaro, inform your prescriber immediately if you're prescribed new medications by your GP or hospital specialist. We recommend keeping an updated medication list in your phone and sharing it at every healthcare appointment. If you develop persistent abdominal pain, visual changes, or signs of allergic reaction, stop Mounjaro and seek urgent medical advice.

Scientific References

1. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Rosenstock, J., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143–155. https://doi.org/10.1016/S0140-6736(21)01324-6
3. Medicines and Healthcare products Regulatory Agency. (2023). Tirzepatide (Mounjaro): Summary of Product Characteristics. MHRA. https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
4. Nauck, M. A., et al. (2021). Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors. Circulation, 144(10), 804–827. https://doi.org/10.1161/CIRCULATIONAHA.121.054024

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication or if you have concerns about drug interactions.